+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications



Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications



Current Medicinal Chemistry 17(3): 254-263



Angiogenesis plays an important role in the pathogenesis of inflammatory diseases, including rheumatoid arthritis (RA). The site and extent of inflammation and subsequent joint destruction in the rheumatoid synovium is dependent on the development of new vasculature. Inhibition of angiogenesis, extensively studied in cancer, might therefore be of interest as treatment option for RA. Hypoxia-inducible factor-1 (HIF-1) has been reported to play a critical role in the regulation of hypoxia driven angiogenesis. HIF-1 is a transcription factor that is constitutively expressed in many cells. It gains transcriptional activity in hypoxic cells leading to the expression of genes involved in angiogenesis. The synovium is hypoxic, but also in an inflammatory environment such as seen in RA, inflammatory cytokines may be important inducers of HIF-1 expression and/or activation. Many drugs currently used in the treatment of RA have anti-angiogenic effects, which are exerted at different levels. Blocking of TNF-alpha, for instance, reduces TNF-alpha induced VEGF production. Studies aiming at direct inhibition of pro-angiogenic factors, such as inhibiting VEGF- or FGF-receptor signalling or blocking VEGF by monoclonal anti-VEGF antibody therapeutics, are in progress. Inhibition of HIF-1 expression or activation, either by blocking signal transduction pathways leading to HIF-1 induction or by inhibiting accumulation of HIF -1 protein, represents a new strategy, which is of interest for the treatment of RA. This review will concisely summarize the general knowledge on the molecular control of gene expression by HIF-1, its involvement in RA, and potential for therapeutic intervention at the level of HIF-1 activity.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 053640530

Download citation: RISBibTeXText

PMID: 20214567


Related references

Hypoxia-Inducible Factor-1 as Regulator of Angiogenesis in Rheumatoid Arthritis - Therapeutic Implications. Current Medicinal Chemistry 17(3): 254-263, 2010

Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. Plos Biology 12(6): E1001881, 2014

Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clinical and Experimental Rheumatology 27(6): 945-951, 2010

Hypoxia-inducible factor: a potential therapeutic target for rheumatoid arthritis. Current Drug Targets 14(6): 700-707, 2013

Hypoxia-Inducible Factor A Potential Therapeutic Target for Rheumatoid Arthritis. 2013

Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. Arthritis and Rheumatism 44(7): 1540-1544, 2001

Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritis. Arthritis and Rheumatism 50(1): 10-23, 2004

BMK1/ERK5 is a novel regulator of angiogenesis by destabilizing hypoxia inducible factor 1alpha. Circulation Research 96(11): 1145-1151, 2005

Naked DNA encoding and hypoxia-inducible factor 1alpha /VP16 hybrid transcription factor enhances angiogenesis in rabbit hindlimb ischemia An alternate method for therapeutic angiogenesis utilizaing a transcriptional regulatory system. Circulation. 98(17 Suppl.): I68,. 27, 1998

Naked DNA encoding a hypoxia-inducible factor 1alpha /VP16 hybrid transcription factor enhances angiogenesis in rabbit hindlimb ischemia An alternate method for therapeutic angiogenesis utilizing a transcriptional regulatory system. Circulation 98(17 Suppl. ): IO, 1998

Rnd3/RhoE Modulates Hypoxia-Inducible Factor 1α/Vascular Endothelial Growth Factor Signaling by Stabilizing Hypoxia-Inducible Factor 1α and Regulates Responsive Cardiac Angiogenesis. Hypertension 67(3): 597-605, 2016

Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Annals of the Rheumatic Diseases 73(5): 928-936, 2014

MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Research 66(2): 856-866, 2006

Role of hypoxia-inducible factor in the pathogenesis of rheumatoid arthritis. Beijing Da Xue Xue Bao. Yi Xue Ban 48(6): 1095-1099, 2016

Hypoxia-Inducible Factor (HIF) as a Target for Novel Therapies in Rheumatoid Arthritis. Frontiers in Pharmacology 7: 184, 2016